Literature DB >> 26897595

Meganuclease-Mediated COL7A1 Gene Correction for Recessive Dystrophic Epidermolysis Bullosa.

Araksya Izmiryan1, Olivier Danos2, Alain Hovnanian3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26897595     DOI： 10.1016/j.jid.2015.11.028

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN： 0022-202X            Impact factor:   8.551


× No keyword cloud information.
  16 in total

1.  CRISPR/Cas9-Mediated In Situ Correction of LAMB3 Gene in Keratinocytes Derived from a Junctional Epidermolysis Bullosa Patient.

Authors:  Daniela Benati; Francesca Miselli; Fabienne Cocchiarella; Clarissa Patrizi; Marta Carretero; Samantha Baldassarri; Virginia Ammendola; Cristina Has; Stefano Colloca; Marcela Del Rio; Fernando Larcher; Alessandra Recchia
Journal:  Mol Ther       Date:  2018-08-04       Impact factor: 11.454

2.  Venturing into the New Science of Nucleases.

Authors:  Markéta Tolarová; John A McGrath; Jakub Tolar
Journal:  J Invest Dermatol       Date:  2016-04       Impact factor: 8.551

3.  Indirect DNA Sequence Recognition and Its Impact on Nuclease Cleavage Activity.

Authors:  Abigail R Lambert; Jazmine P Hallinan; Betty W Shen; Jennifer K Chik; Jill M Bolduc; Nadia Kulshina; Lori I Robins; Brett K Kaiser; Jordan Jarjour; Kyle Havens; Andrew M Scharenberg; Barry L Stoddard
Journal:  Structure       Date:  2016-04-28       Impact factor: 5.006

Review 4.  Raising Awareness Among Healthcare Providers about Epidermolysis Bullosa and Advancing Toward a Cure.

Authors:  Aaron Tabor; Joseph V Pergolizzi; Guy Marti; John Harmon; Bernard Cohen; Jo Ann Lequang
Journal:  J Clin Aesthet Dermatol       Date:  2017-05-01

5.  Correction of recessive dystrophic epidermolysis bullosa by homology-directed repair-mediated genome editing.

Authors:  Jose Bonafont; Angeles Mencía; Esteban Chacón-Solano; Wai Srifa; Sriram Vaidyanathan; Rosa Romano; Marta Garcia; Rosario Hervás-Salcedo; Laura Ugalde; Blanca Duarte; Matthew H Porteus; Marcela Del Rio; Fernando Larcher; Rodolfo Murillas
Journal:  Mol Ther       Date:  2021-02-18       Impact factor: 12.910

6.  Deletion of a Pathogenic Mutation-Containing Exon of COL7A1 Allows Clonal Gene Editing Correction of RDEB Patient Epidermal Stem Cells.

Authors:  Ángeles Mencía; Cristina Chamorro; Jose Bonafont; Blanca Duarte; Almudena Holguin; Nuria Illera; Sara G Llames; Maria José Escámez; Ingrid Hausser; Marcela Del Río; Fernando Larcher; Rodolfo Murillas
Journal:  Mol Ther Nucleic Acids       Date:  2018-01-31       Impact factor: 8.886

7.  CRISPR/Cas9-based genetic correction for recessive dystrophic epidermolysis bullosa.

Authors:  Beau R Webber; Mark J Osborn; Amber N McElroy; Kirk Twaroski; Cara-Lin Lonetree; Anthony P DeFeo; Lily Xia; Cindy Eide; Christopher J Lees; Ron T McElmurry; Megan J Riddle; Chong Jai Kim; Dharmeshkumar D Patel; Bruce R Blazar; Jakub Tolar
Journal:  NPJ Regen Med       Date:  2016-12-08

8.  Ex Vivo COL7A1 Correction for Recessive Dystrophic Epidermolysis Bullosa Using CRISPR/Cas9 and Homology-Directed Repair.

Authors:  Araksya Izmiryan; Clarisse Ganier; Matteo Bovolenta; Alain Schmitt; Fulvio Mavilio; Alain Hovnanian
Journal:  Mol Ther Nucleic Acids       Date:  2018-06-26       Impact factor: 8.886

Review 9.  RNA-based therapies for genodermatoses.

Authors:  Olivier Bornert; Patricia Peking; Jeroen Bremer; Ulrich Koller; Peter C van den Akker; Annemieke Aartsma-Rus; Anna M G Pasmooij; Eva M Murauer; Alexander Nyström
Journal:  Exp Dermatol       Date:  2017-01       Impact factor: 3.960

Review 10.  Investigational Treatments for Epidermolysis Bullosa.

Authors:  Ping-Chen Hou; Han-Tang Wang; Stasha Abhee; Wei-Ting Tu; John A McGrath; Chao-Kai Hsu
Journal:  Am J Clin Dermatol       Date:  2021-07-22       Impact factor: 7.403
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.